{"transactions":[{"id":1433892,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":88308,"kind":"person","name":"Greenberg Bruce","position":1,"cik":"0001928391","reported_name":"Greenberg Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-14T16:24:15.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":10834,"price":4.7363,"value":51313.0742,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the settlement of certain time-based restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $4.46 to $5.12. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 7,062 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan."}],"balance_after":126382,"source":{"system":"sec-edgar","filing":"0000950170-24-097070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1928391/000095017024097070/ownership.xml","form_type":"4"}},{"id":1540188,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":88308,"kind":"person","name":"Greenberg Bruce","position":1,"cik":"0001928391","reported_name":"Greenberg Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-04-17T16:10:37.000Z","date":"2024-03-11","kind":"sale","planned":false,"acquired":false,"shares":13201,"price":3.4064,"value":44967.8864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the settlement of certain time-based restricted stock unit awards.  This sale was previously reported in the Reporting Person's Form 4 filed on March 12, 2024 (the \"Original Form 4\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.27 to $3.58. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Adjusted to reflect 9,455 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan, which were inadvertently omitted in the Original Form 4. The amount in Column 5 of this Form 4 reflects the number of shares beneficially owned by the Reporting Person as of the date of this report after giving effect to the adjustment."}],"balance_after":130154,"source":{"system":"sec-edgar","filing":"0000950170-24-045108","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1928391/000095017024045108/ownership.xml","form_type":"4/A","original_submission_date":"2024-03-12"}},{"id":1581750,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":88308,"kind":"person","name":"Greenberg Bruce","position":1,"cik":"0001928391","reported_name":"Greenberg Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-12T20:07:22.000Z","date":"2024-03-09","kind":"grant","planned":false,"acquired":true,"shares":252280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2024."}],"balance_after":252280,"derivative":{"exercise_price":3.62,"expiration_date":"2034-03-08","underlying":"Common Stock","underlying_shares":252280},"source":{"system":"sec-edgar","filing":"0000950170-24-030314","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1928391/000095017024030314/ownership.xml","form_type":"4"}},{"id":1581749,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":88308,"kind":"person","name":"Greenberg Bruce","position":1,"cik":"0001928391","reported_name":"Greenberg Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-12T20:07:22.000Z","date":"2024-03-11","kind":"sale","planned":false,"acquired":false,"shares":13201,"price":3.4064,"value":44967.8864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the settlement of certain time-based restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.27 to $3.58. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":120699,"source":{"system":"sec-edgar","filing":"0000950170-24-030314","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1928391/000095017024030314/ownership.xml","form_type":"4"}},{"id":1980121,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":88308,"kind":"person","name":"Greenberg Bruce","position":1,"cik":"0001928391","reported_name":"Greenberg Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-02T16:25:46.000Z","date":"2023-02-28","kind":"grant","acquired":false,"shares":110028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2023."}],"balance_after":110028,"derivative":{"exercise_price":6.76,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":110028},"source":{"system":"sec-edgar","filing":"0000899243-23-006746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1928391/000089924323006746/doc4.xml","form_type":"4"}},{"id":2205521,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":88308,"kind":"person","name":"Greenberg Bruce","position":1,"cik":"0001928391","reported_name":"Greenberg Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-07-19T16:34:33.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":126087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on July 15, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date."}],"balance_after":133900,"source":{"system":"sec-edgar","filing":"0000899243-22-026345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1928391/000089924322026345/doc4.xml","form_type":"4"}}]}